Research Topics
Genomes and GenesSpecies | Martin AignerSummaryAffiliation: Medical University of Vienna Country: Austria Publications
| Collaborators
|
Detail Information
Publications
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disordersMartin Aigner
Department of Psychiatry and Psychotherapy, Medical University Vienna MUW, Vienna, Austria
World J Biol Psychiatry 12:400-43. 2011..In this review recommendations for the pharmacological treatment of eating disorders (anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED)) are presented, based on the available literature...
Magnetic resonance imaging in patients with obsessive-compulsive disorder with good versus poor insightMartin Aigner
Department of Psychiatry, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Psychiatry Res 140:173-9. 2005..This distinction should be taken into account in future studies concerning the course and therapeutic outcome of OCD...
What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorderMartin Aigner
Dept of Psychiatry, Medical University of Vienna, Vienna, Austria
Soc Psychiatry Psychiatr Epidemiol 41:81-6. 2006..This study addresses the quality of life of patients with chronic somatoform pain and its relation to depressive symptoms...
High prevalence of restless legs syndrome in somatoform pain disorderMartin Aigner
Department of Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Eur Arch Psychiatry Clin Neurosci 257:54-7. 2007..Restless legs syndrome is associated with painful symptoms and sleep disturbances. The aim of our study was to evaluate the prevalence of restless legs syndrome (RLS) in somatoform pain disorder...
Cognitive and emotion recognition deficits in obsessive-compulsive disorderMartin Aigner
Department of Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Psychiatry Res 149:121-8. 2007..The results point to memory and executive deficits in addition to a "negative" bias in emotion recognition in OCD patients...
Diencephalic serotonin transporter availability predicts both transporter occupancy and treatment response to sertraline in obsessive-compulsive checkersWerner Zitterl
Department of Psychiatry and Psychotherapy, Medical University of Vienna, A 1090 Vienna, Austria
Biol Psychiatry 66:1115-22. 2009....
Sleep disturbances in somatoform pain disorderMartin Aigner
Department of Psychiatry, University of Vienna, Vienna, Austria
Psychopathology 36:324-8. 2003..The aim of the study was to evaluate the frequency of sleep disorder in patients with somatoform pain disorder and to correlate it with comorbid depression, pain parameters and psychosocial parameters...
Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorderWerner Zitterl
Department of Psychiatry, Medical University of Vienna, Vienna, Austria
Neuropsychopharmacology 33:3126-34. 2008..145+/-4.514; t=3.133; p=0.005). These results provide further support for an important role of alterations in serotonergic neurons in the pathophysiology of OCD...
Antipsychotics for acute and chronic pain in adultsStefan Seidel
Department of Neurology, Medical University of Vienna, Vienna, Austria
J Pain Symptom Manage 39:768-78. 2010..g., chronic headache, fibromyalgia, and painful diabetic neuropathy). With atypical antipsychotics, a new class of antipsychotics, with fewer extrapyramidal side effects and additional benefits, may be available...
[123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkersWerner Zitterl
Department of Psychiatry, Medical University of Vienna, Vienna, Austria
Neuropsychopharmacology 32:1661-8. 2007..The results provide direct evidence for an involvement of the serotonergic system in the pathophysiology of OCD...
Dysfunctional pain modulation in somatoform pain disorder patientsStefanie Klug
Department of Psychiatry and Psychotherapy, General Hospital of Vienna, Medical University of Vienna, Wahringer Gurtel 18 20, Vienna, Austria
Eur Arch Psychiatry Clin Neurosci 261:267-75. 2011..We finally conclude that obtained results may point to an altered baseline activity, maybe characteristic for chronic somatoform pain disorder...
Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta databaseBernd Saletu
Department of Psychiatry, Medical University of Vienna, Vienna, Austria
Neuropsychobiology 51:148-63. 2005..Our study provided the first evidence on the usefulness of the Somnolyzer 24 x 7 and the Siesta database in clinical practice...
[The psychic structure of chronic pain patients]Melitta Fischer-Kern
Universitätsklinik für Psychoanalyse und Psychotherapie, Medizinische Universität Wien, A 1090 Wien
Z Psychosom Med Psychother 56:34-46. 2010..The study investigates the psychic structure and psychiatric comorbidity of chronic pain patients according to Kernberg's concept of personality organization...
The relationship between personality organization and psychiatric classification in chronic pain patientsMelitta Fischer-Kern
Department of Psychoanalysis and Psychotherapy, Medical University of Vienna, Vienna, Austria
Psychopathology 44:21-6. 2011..The present study investigated the relationship between psychiatric classification and personality organization (PO) in a secondary/tertiary clinical sample of chronic pain patients (CPPs)...
Manifest psychosis in neurosyphilisFabian Friedrich
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna 1090, Austria
Gen Hosp Psychiatry 31:379-81. 2009..Recent surveys have assessed a remarkable increase in the prevalence of infectious syphilis. If left untreated, 30% of patients may develop tertiary syphilis, which can manifest as neurosyphilis...
Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trialsMarkus Dold
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria
Int J Neuropsychopharmacol 16:557-74. 2013..Further trials, mainly with higher antipsychotic doses, are required to optimize pharmacological treatment recommendations for SRI-refractory OCD...
Effect of information on reported adverse events in a placebo-controlled trialMichael Ossege
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Drug Saf 28:81-7. 2005..We hypothesised that information about the likelihood of receiving placebo might influence the perception of adverse effects in volunteers participating in a clinical trial...
